Will some efforts fall to the wayside if researchers put too many eggs into the antiamyloid basket?
A single therapy is unlikely to prove the solution to Alzheimer’s disease. Current therapies focus on slowing the disorder’s progression and aim to preserve mental function and to manage behavioral symptoms. Success could lie in a wide range of interventions, including immunotherapy, antiamyloid or anti-tau drugs, cognitive training, physical activity, and improved treatments for comorbid conditions like cardiovascular disease and diabetes.
New insights suggest the tau protein is crucial in cognitive decline.
Dr. Andrew Budson discusses ways you can detect memory disorders in patients like Steve Johanson
Amyloid – A culprit? A conspirator? A bystander? Or all three?